TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.【JP:E25678】
Market cap
P/E ratio
| Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | |
| Profit (loss) before income taxes | 43,208 | 51,316 | 40,162 | 35,809 | 41,956 | 48,070 | 64,484 | 30,311 | 22,976 | 21,398 | 29,498 |
| Depreciation | 10,951 | 11,042 | 11,561 | 11,117 | 10,423 | 10,154 | 10,073 | 12,610 | 14,700 | 15,379 | 16,398 |
| Amortization of goodwill | 1,103 | 1,345 | 1,377 | 1,356 | 1,247 | 1,226 | 1,217 | 5,329 | 7,341 | 7,695 | 8,250 |
| Gain on reversal of share acquisition rights | - | - | - | - | - | - | - | - | - | -38 | - |
| Loss (gain) on sale of non-current assets | -1,606 | -120 | -1,035 | -19 | -14 | -619 | -37 | 74 | -11 | 45 | -90 |
| Loss (gain) on disposal of non-current assets | 239 | 105 | 396 | 134 | 184 | 288 | 80 | 127 | 510 | 86 | 270 |
| Loss (gain) on sale of investment securities | - | -56 | - | - | -4,090 | -5,598 | - | - | 67 | -4,069 | -1 |
| Loss (gain) on valuation of investment securities | 2,199 | - | - | - | - | - | - | - | 152 | 720 | 1,501 |
| Loss (gain) on sale of shares of subsidiaries and associates | - | - | - | - | - | - | -42,944 | - | - | - | -800 |
| Impairment losses | - | - | - | 850 | - | - | 2,916 | 592 | 2,250 | 269 | 65 |
| Interest and dividend income | -6,445 | -6,499 | -6,691 | -6,831 | -6,739 | -6,723 | -6,849 | -5,760 | -3,619 | -3,449 | -3,831 |
| Interest expenses | 17 | 2 | 2 | 2 | 1 | 2 | 2 | 118 | 156 | 170 | 169 |
| Foreign exchange losses (gains) | - | - | - | - | - | - | -508 | 3,831 | -1,730 | -3,588 | -2,719 |
| Share of loss (profit) of entities accounted for using equity method | -1,590 | -2,473 | -255 | -382 | 601 | 1,634 | -1,689 | -272 | -276 | -305 | -314 |
| Increase (decrease) in allowance for doubtful accounts | -1 | -106 | -288 | -23 | -1 | 9 | 54 | 60 | -9 | -60 | -76 |
| Increase (decrease) in retirement benefit liability | - | 1,362 | 2,786 | 1,357 | -183 | -133 | -5,365 | 48 | 228 | 18 | -494 |
| Decrease (increase) in retirement benefit asset | - | 2,893 | -4,417 | 6,434 | -1,927 | -734 | -2,534 | 1,122 | -23 | -619 | 233 |
| Increase (decrease) in provision for retirement benefits for directors (and other officers) | 37 | -27 | -207 | -165 | -214 | 18 | 5 | - | -61 | 22 | 34 |
| Increase (decrease) in provision for bonuses | -60 | -39 | -692 | -77 | 4 | 3 | -744 | -1,897 | -271 | 72 | 400 |
| Decrease (increase) in trade receivables | -2,034 | 5,834 | -931 | 4,250 | 5,365 | -5,393 | 3,686 | 11,849 | 13,662 | -2,868 | 2,812 |
| Decrease (increase) in inventories | 8 | -1,133 | -5 | 465 | -1,025 | 1,167 | -2,788 | 1,601 | -2,905 | 2,539 | -6,938 |
| Increase (decrease) in trade payables | -2,167 | -641 | 857 | -1,765 | -3,655 | -3,531 | -1,053 | -4,927 | -3,303 | 384 | 1,257 |
| Increase (decrease) in accrued expenses | - | - | - | - | - | - | - | 3,214 | -4,141 | 2,066 | 1,516 |
| Other, net | 227 | -2,166 | 625 | -7,045 | 2,602 | 4,255 | 1,140 | 3,635 | -1,324 | -1,903 | 9 |
| Subtotal | 43,219 | 60,659 | 43,299 | 45,317 | 44,454 | 43,894 | 35,069 | 50,359 | 44,345 | 33,966 | 47,153 |
| Interest and dividends received | 6,543 | 6,623 | 6,842 | 6,923 | 6,954 | 7,643 | 11,251 | 5,892 | 4,043 | 3,386 | 4,197 |
| Interest paid | -17 | -2 | -2 | -2 | -1 | -2 | -2 | -119 | -173 | -158 | -173 |
| Income taxes paid | -13,541 | -9,934 | -20,382 | -9,285 | -11,435 | -11,772 | -15,039 | -16,513 | -11,615 | -8,872 | -10,800 |
| Income taxes refund | 5,087 | 2,887 | 3,958 | 104 | 95 | 88 | 111 | 2,373 | 5,427 | 184 | 595 |
| Net cash provided by (used in) operating activities | 41,292 | 60,233 | 33,714 | 43,058 | 40,066 | 39,852 | 19,222 | 41,992 | 42,026 | 28,506 | 40,972 |
| Decrease (increase) in time deposits | 187 | 4,280 | -2,941 | -2,165 | 135 | -9,763 | 6,223 | -10,286 | 1,362 | 553 | 16,688 |
| Payments into long-term time deposits | - | - | - | - | - | - | - | - | - | - | -2,632 |
| Proceeds from sale and redemption of securities | 19,000 | 14,300 | 14,000 | 10,000 | 34,200 | - | 29,396 | 74,500 | 14,000 | 4,000 | 7,200 |
| Purchase of property, plant and equipment | -11,285 | -9,820 | -5,264 | -6,923 | -7,322 | -2,726 | -3,434 | -5,456 | -10,251 | -10,040 | -26,433 |
| Proceeds from sale of property, plant and equipment | 1,773 | 227 | 1,329 | 33 | 39 | 868 | 27 | 321 | 37 | 39 | 617 |
| Purchase of intangible assets | -1,396 | -5,040 | -500 | -1,291 | -1,508 | -2,287 | -1,480 | -3,665 | -4,121 | -4,349 | -23,946 |
| Purchase of investment securities | -11,075 | -23,013 | -24,500 | -11,147 | -20,828 | -12,472 | -18,866 | -1,858 | -2,068 | -1,269 | -781 |
| Proceeds from sale and redemption of investment securities | 39 | 183 | - | - | 6,554 | 6,317 | - | 111 | 39 | 5,272 | 133 |
| Purchase of long-term prepaid expenses | -474 | -407 | -309 | -295 | -380 | -470 | -147 | -499 | -374 | -1,278 | -118 |
| Proceeds from sale of shares of subsidiaries resulting in change in scope of consolidation | - | - | - | - | - | - | - | - | - | - | 1,512 |
| Other, net | -651 | -47 | 22 | 126 | 10 | 1,061 | 87 | 250 | -580 | 9 | 630 |
| Net cash provided by (used in) investing activities | -9,359 | -21,998 | -18,162 | -11,662 | -1,361 | -19,908 | 66,044 | -107,081 | -1,958 | -7,063 | -27,130 |
| Proceeds from short-term borrowings | 99 | 270 | 170 | 180 | 290 | 378 | 211 | 270 | 4,854 | 4,397 | 5,660 |
| Repayments of short-term borrowings | -514 | -255 | -225 | -305 | -232 | -365 | -187 | -1,534 | -5,037 | -4,302 | -6,282 |
| Repayments of finance lease liabilities | -251 | -136 | -106 | -111 | -103 | -116 | -110 | -73 | -503 | -349 | -442 |
| Purchase of treasury shares | -61 | -110 | -97 | -10,097 | -100 | -96 | -125 | -48 | -41 | -43 | -34 |
| Dividends paid | -8,858 | -8,894 | -8,900 | -8,903 | -7,974 | -8,771 | -8,773 | -9,586 | -8,787 | -7,415 | -8,206 |
| Dividends paid to non-controlling interests | - | - | -284 | -288 | -284 | -895 | -4,517 | -722 | -1,830 | -2,343 | -1,571 |
| Other, net | - | - | - | - | - | - | - | - | - | - | - |
| Net cash provided by (used in) financing activities | -10,064 | -9,439 | -9,443 | -19,525 | -8,404 | -9,867 | -15,467 | -11,696 | -11,346 | -10,057 | -10,877 |
| Effect of exchange rate change on cash and cash equivalents | 864 | 1,221 | 1,031 | -640 | -348 | 67 | -570 | 177 | -317 | 780 | 1,595 |
| Net increase (decrease) in cash and cash equivalents | 22,733 | 30,017 | 7,139 | 11,229 | 29,952 | 10,143 | 69,228 | -76,607 | 28,404 | 12,166 | 4,560 |